To reduce stigmatization
Share
1,111,111 TRP = 11,111 USD
1,111,111 TRP = 11,111 USD
1,111,111 TRP = 11,111 USD
Reset Your New Password Now!
Lost your password? Please enter your email address. You will receive a link and will create a new password via email.
Please briefly explain why you feel this question should be reported.
Please briefly explain why you feel this memory should be reported.
Please briefly explain why you feel this user should be reported.
To reduce stigmatization
HIV and AIDS in 2025: Is There a Cure?
As of 2025, HIV remains incurable, but advancements in treatment have transformed it into a manageable chronic condition. Antiretroviral therapy (ART) suppresses the virus to undetectable levels, preventing progression to AIDS and transmission to others. However, ART requires lifelong adherence.
Recent Breakthroughs:
Functional Cures: A handful of cases (e.g., the “Berlin Patient” and “London Patient”) achieved long-term remission through risky stem cell transplants from donors with HIV-resistant mutations. These are not scalable solutions.
Gene Editing: CRISPR-based therapies (e.g., EBT-101) show promise in early trials by targeting HIV DNA in reservoirs, but widespread use is years away.
Vaccines and mRNA Tech: Moderna’s mRNA HIV vaccine trials are ongoing, but no preventive or therapeutic vaccine has been approved yet.
Challenges:
HIV’s ability to hide in reservoirs makes eradication difficult.
Access to treatment remains unequal, especially in regions like sub-Saharan Africa (including Nigeria), where stigma and funding gaps persist.
Bottom Line: While science inches closer to a cure, current tools focus on suppression and prevention (e.g., PrEP). A true cure likely requires another decade of research. For now, early testing and consistent ART are critical.